| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 9, 2023 | STAA Staar Surgical Co | Broadwood Partners, L.P.60 | 10% Owner | Buy | 289,140 | $33.42 | $9,662,781.63 | +0.4% | -9.3% | -9.5% | |
| Nov 8, 2023 | NVST Envista Holdings Corp | Nance Mark E68 | General Counsel | Buy | 5,000 | $21.75 | $108,750.00 | +14.7% | +13.0% | -1.3% | |
| Nov 8, 2023 | DXCM Dexcom Inc | Regan Barry J.60 | EVP Operations | Sell | 2,019 | $95.22 | $192,249.18 | -3.0% | +34.7% | -25.7% | |
| Nov 8, 2023 | TNDM Tandem Diabetes Care Inc | Hansen Shannon Marie | Chief Legal Officer | Buy | 1,935 | $15.44 | $29,884.33 | New | +55.7% | +114.7% | |
| Nov 8, 2023 | TNDM Tandem Diabetes Care Inc | Vosseller Leigh74 | EVP &Chief Financial Officer | Buy | 6,200 | $15.39 | $95,395.06 | +109.5% | +55.7% | +114.7% | |
| Nov 7, 2023 | NVCR Novocure Ltd | Shah Pritesh75 | Chief Growth Officer | Sell | 382 | $12.65 | $4,832.30 | -0.3% | +6.7% | +40.6% | |
| Nov 7, 2023 | CTKB Cytek Biosciences, Inc. | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $4.34 | $86,800.00 | -0.4% | +71.5% | +66.3% | |
| Nov 7, 2023 | CNMD Conmed Corp | Peters Stanley W III79 | President As And Aet | Sell | 1,200 | $102.40 | $122,874.00 | -95.0% | -18.0% | -24.8% | |
| Nov 7, 2023 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 15,000 | $64.32 | $964,800.00 | -2.8% | +42.5% | +42.1% | |
| Nov 7, 2023 | IRMD Iradimed Corp | Susi Roger E.53 | CEO, President, Chairman | Sell | 10,000 | $42.12 | $421,246.50 | -2.1% | +9.4% | +36.7% | |
| Nov 6, 2023 | NVST Envista Holdings Corp | Aghdaei Amir65 | Chief Executive Officer | Buy | 10,000 | $21.53 | $215,253.07 | +0.9% | +11.3% | -1.1% | |
| Nov 6, 2023 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 4,984 | $0.45 | $2,218.88 | -0.9% | -15.3% | -42.0% | |
| Nov 6, 2023 | BSX Boston Scientific Corp | Mahoney Michael F57 | Chairman, President &CEO | Sell | 113,356 | $52.51 | $5,951,983.49 | -7.0% | +22.1% | +62.0% | |
| Nov 6, 2023 | NVST Envista Holdings Corp | Keller Stephen | Principal Financial Officer | Buy | 2,000 | $21.53 | $43,060.00 | +18.1% | +11.3% | -1.1% | |
| Nov 6, 2023 | STAA Staar Surgical Co | Broadwood Partners, L.P.60 | 10% Owner | Buy | 309,154 | $34.93 | $10,797,514.02 | +0.4% | -19.8% | -13.0% | |
| Nov 3, 2023 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Director | Sell | 29,350 | $67.18 | $1,971,733.00 | -86.7% | +17.4% | +0.7% | |
| Nov 3, 2023 | NEOG Neogen Corp | Boehm William T67 | Director | Buy | 2,000 | $16.06 | $32,110.00 | +8.2% | -3.3% | -8.7% | |
| Nov 2, 2023 | EKSO Ekso Bionics Holdings, Inc. | Lathan Corinna59 | Director | Buy | 13,733 | $1.13 | $15,477.47 | +3.3% | +84.7% | -28.5% | |
| Nov 2, 2023 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 406 | $17.52 | $7,113.40 | -0.8% | +15.5% | -22.9% | |
| Nov 1, 2023 | MODD Modular Medical, Inc. | Sheibley Philip Brent55 | Director | Buy | 10,000 | $1.29 | $12,900.00 | +27.7% | +47.9% | +79.3% | |
| Nov 1, 2023 | RMD Resmed Inc | Rider Michael J49 | Global General Counsel | Sell | 25 | $143.42 | $3,585.50 | -0.3% | +30.0% | +64.7% | |
| Nov 1, 2023 | ARAY Accuray Inc | Winter Suzanne C63 | President | Sell | 38,338 | $2.57 | $98,528.66 | -2.6% | +5.1% | -32.7% | |
| Nov 1, 2023 | ATRC Atricure, Inc. | Dahlquist Karl S.69 | Chief Legal Officer | Sell | 1,248 | $34.43 | $42,968.64 | -3.9% | -3.1% | -5.2% | |
| Oct 31, 2023 | ARAY Accuray Inc | Pervaiz Ali63 | SVP Chief Financial Officer | Sell | 3,303 | $2.58 | $8,533.96 | -0.8% | +8.3% | -28.8% | |
| Oct 31, 2023 | EW Edwards Lifesciences Corp | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 7,255 | $62.66 | $454,568.55 | -27.4% | +17.0% | +7.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.